Full Press Release Details
Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency
January 16, 2024 (Globe Newswire) - EUDA Health Holdings Limited ("EUDA" and the "Company") received a written
notice (the "MVLS Notice") from Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on January
9, 2024 indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities ("MVLS") of $35 million
over the previous 30 consecutive business days as required by the Nasdaq Listing Rule 5550(b)(2).
MVLS Notice has no immediate effect on the listing of the Company's securities on Nasdaq and the Company has been provided a period
of 180 calendar days from the date of the MVLS Notice, or until July 8, 2024, in which to regain compliance (the "MVLS Compliance
Period"). In order to regain compliance with Nasdaq Listing Rule 5550(b)(2), the Market Value of Listed Securities of the Company
must close at $35,000,000 or more for a minimum of ten consecutive business days during the MVLS Compliance Period.
the event that the Company does not regain compliance with Nasdaq Listing Rule 5550(b)(2) within the MVLS Compliance Period, Nasdaq will
provide notice to the Company that its listed securities will be subject to delisting. In the event of such notification, the Company
may appeal Nasdaq's determination to delist its securities, but there can be no assurance that Nasdaq would grant the Company's
request for continued listing.
investor and media inquiries, please contact:
Health Holdings Limited